IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX) have received an average rating of “Moderate Buy” from the six research firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $53.3333.

A number of research analysts have commented on IPX shares. Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a research report on Tuesday, April 28th. BTIG Research lifted their price target on shares of IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, June 5th. Roth Capital set a $53.00 price target on shares of IperionX in a research note on Wednesday, August 5th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a report on Friday, July 17th.

IperionX Price Performance

NASDAQ IPX opened at $22.50 on Monday. The stock has a fifty day simple moving average of $25.30 and a 200-day simple moving average of $32.76. The company has a current ratio of 4.03, a quick ratio of 4.00 and a debt-to-equity ratio of 0.03. IperionX has a twelve month low of $20.05 and a twelve month high of $61.45.

Insider Buying and Selling

In other news, Chairman Todd Hannigan purchased 300,000 shares of the stock in a transaction dated Monday, July 13th. The stock was acquired at an average cost of $3.59 per share, for a total transaction of $1,077,000.00. Following the completion of the transaction, the chairman directly owned 26,633,334 shares in the company, valued at approximately $95,613,669.06. This represents a 1.14% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Anastasios Arima acquired 138,720 shares of the company’s stock in a transaction dated Friday, July 10th. The stock was purchased at an average cost of $3.58 per share, with a total value of $496,617.60. Following the completion of the purchase, the chief executive officer directly owned 12,455,502 shares of the company’s stock, valued at approximately $44,590,697.16. This represents a 1.13% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders acquired 663,720 shares of company stock worth $2,379,118.

Hedge Funds Weigh In On IperionX

Hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC grew its position in IperionX by 40.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock valued at $50,000 after acquiring an additional 483 shares in the last quarter. JPMorgan Chase & Co. purchased a new stake in IperionX during the second quarter worth about $66,000. State of Tennessee Department of Treasury acquired a new stake in shares of IperionX during the fourth quarter worth about $119,000. DV Equities LLC acquired a new stake in shares of IperionX during the fourth quarter worth about $178,000. Finally, Man Group plc purchased a new position in shares of IperionX in the fourth quarter valued at approximately $257,000. Institutional investors and hedge funds own 2.76% of the company’s stock.

About IperionX

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.